Nystoriak Matthew A, Nieves-Cintrón Madeline, Patriarchi Tommaso, Buonarati Olivia R, Prada Maria Paz, Morotti Stefano, Grandi Eleonora, Fernandes Julia Dos Santos, Forbush Katherine, Hofmann Franz, Sasse Kent C, Scott John D, Ward Sean M, Hell Johannes W, Navedo Manuel F
Department of Pharmacology, University of California, Davis, Davis, CA 95616, USA.
Howard Hughes Medical Institute and Department of Pharmacology, University of Washington, Seattle, WA 98195, USA.
Sci Signal. 2017 Jan 24;10(463):eaaf9647. doi: 10.1126/scisignal.aaf9647.
Hypercontractility of arterial myocytes and enhanced vascular tone during diabetes are, in part, attributed to the effects of increased glucose (hyperglycemia) on L-type Ca1.2 channels. In murine arterial myocytes, kinase-dependent mechanisms mediate the increase in Ca1.2 activity in response to increased extracellular glucose. We identified a subpopulation of the Ca1.2 channel pore-forming subunit (α1) within nanometer proximity of protein kinase A (PKA) at the sarcolemma of murine and human arterial myocytes. This arrangement depended upon scaffolding of PKA by an A-kinase anchoring protein 150 (AKAP150) in mice. Glucose-mediated increases in Ca1.2 channel activity were associated with PKA activity, leading to α1 phosphorylation at Ser Compared to arteries from low-fat diet (LFD)-fed mice and nondiabetic patients, arteries from high-fat diet (HFD)-fed mice and from diabetic patients had increased Ser phosphorylation and Ca1.2 activity. Arterial myocytes and arteries from mice lacking AKAP150 or expressing mutant AKAP150 unable to bind PKA did not exhibit increased Ser phosphorylation and Ca1.2 current density in response to increased glucose or to HFD. Consistent with a functional role for Ser phosphorylation, arterial myocytes and arteries from knockin mice expressing a Ca1.2 with Ser mutated to alanine (S1928A) lacked glucose-mediated increases in Ca1.2 activity and vasoconstriction. Furthermore, the HFD-induced increases in Ca1.2 current density and myogenic tone were prevented in S1928A knockin mice. These findings reveal an essential role for α1 phosphorylation at Ser in stimulating Ca1.2 channel activity and vasoconstriction by AKAP-targeted PKA upon exposure to increased glucose and in diabetes.
糖尿病期间动脉肌细胞的过度收缩和血管张力增强,部分归因于葡萄糖增加(高血糖)对L型Ca1.2通道的影响。在小鼠动脉肌细胞中,激酶依赖性机制介导了细胞外葡萄糖增加时Ca1.2活性的增加。我们在小鼠和人类动脉肌细胞膜上鉴定出了Ca1.2通道孔形成亚基(α1)的一个亚群,其与蛋白激酶A(PKA)的距离在纳米范围内。这种排列取决于小鼠中A激酶锚定蛋白150(AKAP150)对PKA的支架作用。葡萄糖介导的Ca1.2通道活性增加与PKA活性相关,导致α1在丝氨酸位点磷酸化。与低脂饮食(LFD)喂养的小鼠和非糖尿病患者的动脉相比,高脂饮食(HFD)喂养的小鼠和糖尿病患者的动脉中丝氨酸磷酸化和Ca1.2活性增加。缺乏AKAP150或表达无法结合PKA的突变型AKAP150的小鼠的动脉肌细胞和动脉,在葡萄糖增加或HFD刺激下,未表现出丝氨酸磷酸化增加和Ca1.2电流密度增加。与丝氨酸磷酸化的功能作用一致,表达丝氨酸突变为丙氨酸(S1928A)的Ca1.2的敲入小鼠的动脉肌细胞和动脉缺乏葡萄糖介导的Ca1.2活性增加和血管收缩。此外,在S1928A敲入小鼠中,HFD诱导的Ca1.2电流密度和肌源性张力增加被阻止。这些发现揭示了丝氨酸位点α1磷酸化在暴露于葡萄糖增加和糖尿病时通过AKAP靶向的PKA刺激Ca1.2通道活性和血管收缩中的重要作用。